Φορτώνει......
PARK2 loss promotes cancer progression via redox-mediated inactivation of PTEN
Cancer and Parkinson disease (PD) derive from distinct alterations in cellular processes, yet there are pathogenic mutations that are unequivocally linked to both diseases. Here we expand on our recent findings that loss of parkin RBR E3 ubiquitin protein ligase (PRKN, best known as PARK2)—which is...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Mol Cell Oncol |
|---|---|
| Κύριοι συγγραφείς: | , , , |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
Taylor & Francis
2017
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5706935/ https://ncbi.nlm.nih.gov/pubmed/29209642 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/23723556.2017.1329692 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|